-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 9, 2009View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 3, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 27, 2009View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMay 18, 2009View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2009View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-93

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information